title: Authors' reply to Comment on "No impact of interleukin-28B polymorphisms on spontaneous or drug-induced hepatitis delta virus clearance" [Dig. Liver Dis.2014;46:348-52].
authors.affiliation: Clinical Department, National Institute for Infectious Diseases "Lazzaro Spallanzani", Rome, Italy.
authors.forename: Ubaldo
authors.initials: U
authors.lastname: Visco-Comandini
authors.affiliation: Laboratory of Virology, National Institute for Infectious Diseases "Lazzaro Spallanzani", Rome, Italy. Electronic address: daniele.lapa@inmi.it.
authors.forename: Daniele
authors.initials: D
authors.lastname: Lapa
authors.affiliation: Clinical Department, National Institute for Infectious Diseases "Lazzaro Spallanzani", Rome, Italy.
authors.forename: Chiara
authors.initials: C
authors.lastname: Taibi
authors.affiliation: Department of Epidemiology and Pre-clinical Research, National Institute for Infectious Diseases "Lazzaro Spallanzani", Rome, Italy.
authors.forename: Claudio
authors.initials: C
authors.lastname: Angeletti
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D006508:Hepatitis Antibodies / Q000276:immunology*; D019701:Hepatitis D, Chronic / Q000188:drug therapy*; D003698:Hepatitis Delta Virus / Q000276:immunology*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D007378:Interleukins / Q000235:genetics*; D008297:Male; D012367:RNA, Viral / Q000097:blood*
chemical_list: D000998:Antiviral Agents; D006508:Hepatitis Antibodies; D016898:Interferon-alpha; D007378:Interleukins; D012367:RNA, Viral